Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 5
2005 19
2006 23
2007 20
2008 12
2009 19
2010 19
2011 23
2012 15
2013 18
2014 19
2015 24
2016 17
2017 9
2018 15
2019 12
2020 10
2021 9
2022 7
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

264 results
Results by year
Filters applied: . Clear all
Page 1
Insulin.
[No authors listed] [No authors listed] 2022 Nov 30. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2022 Nov 30. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000050 Free Books & Documents. Review.
Mothers with diabetes using insulin may nurse their infants. Exogenous insulin is excreted into breastmilk, including newer biosynthetic insulins (e.g., aspart, deglutec, detemir, glargine glulisine, lispro). Even direct administration of recombinant insul
Mothers with diabetes using insulin may nurse their infants. Exogenous insulin is excreted into breastmilk, including newer bi …
Evolution of insulin: from human to analog.
Tibaldi JM. Tibaldi JM. Am J Med. 2014 Oct;127(10 Suppl):S25-38. doi: 10.1016/j.amjmed.2014.07.005. Am J Med. 2014. PMID: 25282010 Review.
Weight gain is consistently lower with insulin detemir than with neutral protamine Hagedorn insulin. Insulin degludec, licensed in Europe and Japan but not yet in the United States, has a mean half-life of 25.4 hours, a duration of action of >42 hours, and …
Weight gain is consistently lower with insulin detemir than with neutral protamine Hagedorn insulin. Insulin degludec, …
Insulin analogs: Glimpse on contemporary facts and future prospective.
Sharma AK, Taneja G, Kumar A, Sahu M, Sharma G, Kumar A, Sardana S, Deep A. Sharma AK, et al. Life Sci. 2019 Feb 15;219:90-99. doi: 10.1016/j.lfs.2019.01.011. Epub 2019 Jan 10. Life Sci. 2019. PMID: 30639280 Review.
Insulin remains a predominant life-saving medication for type 1 and type 2 Diabetes Mellites. Natural insulin secretion limits the fluctuation of the narrow and high surge of blood glucose levels. ...
Insulin remains a predominant life-saving medication for type 1 and type 2 Diabetes Mellites. Natural insulin secretion limits
Insulin glulisine.
Cox SL. Cox SL. Drugs Today (Barc). 2005 Jul;41(7):433-40. doi: 10.1358/dot.2005.41.7.904726. Drugs Today (Barc). 2005. PMID: 16193096 Review.
One unit of insulin glulisine has the same glucose-lowering effect as one unit of regular human insulin. Insulin glulisine has a favorable safety profile, which is not significantly different from that of regular human insulin. ...
One unit of insulin glulisine has the same glucose-lowering effect as one unit of regular human insulin. Insulin
Insulin glulisine.
Robinson DM, Wellington K. Robinson DM, et al. Drugs. 2006;66(6):861-9. doi: 10.2165/00003495-200666060-00011. Drugs. 2006. PMID: 16706558
Insulin glulisine was generally well tolerated by patients with type 1 or 2 diabetes and had a similar safety profile to insulin lispro or RHI. Severe hypoglycaemia was experienced by similar proportions of insulin glulisine or comparator ins
Insulin glulisine was generally well tolerated by patients with type 1 or 2 diabetes and had a similar safety profile to in
Insulin glulisine: a review of its use in the management of diabetes mellitus.
Garnock-Jones KP, Plosker GL. Garnock-Jones KP, et al. Drugs. 2009 May 29;69(8):1035-57. doi: 10.2165/00003495-200969080-00006. Drugs. 2009. PMID: 19496630 Review.
Insulin glulisine (Apidra) is a human insulin analogue approved for the improvement of glycaemic control in adults, adolescents and children with diabetes mellitus. It has similar binding properties, and is associated with a faster onset but similar level of
Insulin glulisine (Apidra) is a human insulin analogue approved for the improvement of glycaemic control in adults, ado
Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery).
Umpierrez GE, Smiley D, Jacobs S, Peng L, Temponi A, Mulligan P, Umpierrez D, Newton C, Olson D, Rizzo M. Umpierrez GE, et al. Diabetes Care. 2011 Feb;34(2):256-61. doi: 10.2337/dc10-1407. Epub 2011 Jan 12. Diabetes Care. 2011. PMID: 21228246 Free PMC article. Clinical Trial.
RESEARCH DESIGN AND METHODS: This randomized multicenter trial compared the safety and efficacy of a basal-bolus insulin regimen with glargine once daily and glulisine before meals (n = 104) to sliding scale regular insulin (SSI) four times daily (n = 107) in …
RESEARCH DESIGN AND METHODS: This randomized multicenter trial compared the safety and efficacy of a basal-bolus insulin regimen with …
Insulin glulisine complementing basal insulins: a review of structure and activity.
Becker RH. Becker RH. Diabetes Technol Ther. 2007 Feb;9(1):109-21. doi: 10.1089/dia.2006.0035. Diabetes Technol Ther. 2007. PMID: 17316105 Review.
Insulin glulisine has been designed to exhibit intrinsic stability while maintaining rapid deployment of insulin monomers. ...Insulin glulisine complements insulin glargine (21(A)-Gly30(Ba)-L-Arg-30(Bb)-L-Arg-human insulin), the fi
Insulin glulisine has been designed to exhibit intrinsic stability while maintaining rapid deployment of insulin monome
Insulin glulisine: an evaluation of its pharmacodynamic properties and clinical application.
Helms KL, Kelley KW. Helms KL, et al. Ann Pharmacother. 2009 Apr;43(4):658-68. doi: 10.1345/aph.1E662. Epub 2009 Mar 31. Ann Pharmacother. 2009. PMID: 19336657 Review.
DATA SOURCES: Searches were performed with the headings glulisine, insulin analog, [LysB3, GluB29] insulin, insulin glulisine, rDNA insulin, rapid-acting insulin, SoloStar, safety, efficacy, pharmacodynamics, and cost analysis with …
DATA SOURCES: Searches were performed with the headings glulisine, insulin analog, [LysB3, GluB29] insulin, insulin
Insulin glulisine: a new rapid-acting insulin analogue for the treatment of diabetes.
Garg SK, Ellis SL, Ulrich H. Garg SK, et al. Expert Opin Pharmacother. 2005 Apr;6(4):643-51. doi: 10.1517/14656566.6.4.643. Expert Opin Pharmacother. 2005. PMID: 15934890 Review.
In addition, the safe administration of insulin glulisine by continuous subcutaneous insulin infusion has been demonstrated in patients with type 1 diabetes. In conclusion, insulin glulisine is an effective, safe and well-tolerated rapid-acting …
In addition, the safe administration of insulin glulisine by continuous subcutaneous insulin infusion has been demonstr …
264 results